193 related articles for article (PubMed ID: 28217868)
1. An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.
Baakman AC; Alvarez-Jimenez R; Rissmann R; Klaassen ES; Stevens J; Goulooze SC; den Burger JCG; Swart EL; van Gerven JMA; Groeneveld GJ
Br J Clin Pharmacol; 2017 Aug; 83(8):1676-1687. PubMed ID: 28217868
[TBL] [Abstract][Full Text] [Related]
2. Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade.
Voss B; Thienel R; Reske M; Habel U; Kircher T
Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S106-10. PubMed ID: 20960003
[TBL] [Abstract][Full Text] [Related]
3. Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.
Alvarez-Jimenez R; Hart EP; Prins S; de Kam M; van Gerven JMA; Cohen AF; Groeneveld GJ
Br J Clin Pharmacol; 2018 May; 84(5):888-899. PubMed ID: 29319910
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
[TBL] [Abstract][Full Text] [Related]
6. Attenuation in rats of impairments of memory by scopolamine, a muscarinic receptor antagonist, by mecamylamine, a nicotinic receptor antagonist.
Newman LA; Gold PE
Psychopharmacology (Berl); 2016 Mar; 233(5):925-32. PubMed ID: 26660295
[TBL] [Abstract][Full Text] [Related]
7. Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioral, and physiologic responses.
Little JT; Johnson DN; Minichiello M; Weingartner H; Sunderland T
Neuropsychopharmacology; 1998 Jul; 19(1):60-9. PubMed ID: 9608577
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats.
Kim JS; Levin ED
Brain Res; 1996 Jul; 725(2):231-40. PubMed ID: 8836529
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal long term memory: effect of the cholinergic system on local protein synthesis.
Lana D; Cerbai F; Di Russo J; Boscaro F; Giannetti A; Petkova-Kirova P; Pugliese AM; Giovannini MG
Neurobiol Learn Mem; 2013 Nov; 106():246-57. PubMed ID: 24076274
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of muscarinic and nicotinic receptor antagonists on attention and working memory.
McQuail JA; Burk JA
Pharmacol Biochem Behav; 2006 Dec; 85(4):796-803. PubMed ID: 17196638
[TBL] [Abstract][Full Text] [Related]
11. An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds.
Simpraga S; Mansvelder HD; Groeneveld GJ; Prins S; Hart EP; Poil SS; Linkenkaer-Hansen K
Clin Neurophysiol; 2018 Nov; 129(11):2325-2332. PubMed ID: 30248622
[TBL] [Abstract][Full Text] [Related]
12. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
[TBL] [Abstract][Full Text] [Related]
13. Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice.
Leblond L; Beaufort C; Delerue F; Durkin TP
Behav Brain Res; 2002 Jan; 128(1):91-102. PubMed ID: 11755693
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of oral mecamylamine - development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulation.
Alvarez-Jimenez R; Baakman AC; Stevens J; Goulooze SC; Hart EP; Rissmann R; van Gerven JM; Groeneveld GJ
J Psychopharmacol; 2017 Feb; 31(2):192-203. PubMed ID: 27927703
[TBL] [Abstract][Full Text] [Related]
15. Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion.
Ruotsalainen S; Miettinen R; MacDonald E; Koivisto E; Sirviö J
Psychopharmacology (Berl); 2000 Feb; 148(2):111-23. PubMed ID: 10663425
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic, but not nicotinic, acetylcholine receptor blockade in the ventral tegmental area attenuates cue-induced sucrose-seeking.
Addy NA; Nunes EJ; Wickham RJ
Behav Brain Res; 2015 Sep; 291():372-376. PubMed ID: 26026787
[TBL] [Abstract][Full Text] [Related]
17. Dissociable contributions of mediodorsal and anterior thalamic nuclei in visual attentional performance: A comparison using nicotinic and muscarinic cholinergic receptor antagonists.
Mantanona CP; Božič T; Chudasama Y; Robbins TW; Dalley JW; Alsiö J; Pienaar IS
J Psychopharmacol; 2020 Dec; 34(12):1371-1381. PubMed ID: 33103560
[TBL] [Abstract][Full Text] [Related]
18. Additive deficits in the choice accuracy of rats in the delayed non-matching to position task after cholinolytics and serotonergic lesions are non-mnemonic in nature.
Ruotsalainen S; MacDonald E; Miettinen R; Puumala T; Riekkinen P; Sirviö J
Psychopharmacology (Berl); 1997 Apr; 130(4):303-12. PubMed ID: 9160845
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholine contributes through muscarinic receptors to attentional modulation in V1.
Herrero JL; Roberts MJ; Delicato LS; Gieselmann MA; Dayan P; Thiele A
Nature; 2008 Aug; 454(7208):1110-4. PubMed ID: 18633352
[TBL] [Abstract][Full Text] [Related]
20. Mecamylamine reverses physostigmine-induced attenuation of scopolamine-induced hyperactivity.
O'Neill MF; Fernández AG; Gristwood RW; Palacios JM
J Neural Transm Gen Sect; 1994; 96(1):9-18. PubMed ID: 7857593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
